News › Industry News

When it Comes to CBD, the FDA Wants to See the Receipts

June 6, 2019

When it comes to cannabidiol (CBD), the U.S. Food and Drug Administ­ration (FDA) isn’t quite ready to take a hit.
On Friday, May 31, 2019, the agency held its first hearing on CBD in Silver Spring, Maryland. More than 100 people testified, reports CNBC, many of whom extolled the virtues of CBD and its benefits—and implored the agency to set up a regulatory framework to legally add CBD to food products and dietary supplements.
Read more at Skin Inc. >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Accepts Supplemental Biologics License Application for Botox Cosmetic for Masseter Muscle Prominence
    • Medical Spa Show Nominated for Best Tradeshow Injectable Education: 2026 L+A Clinical Collective Awards
    • AmSpa Partners with Allergan Medical Institute to Offer Members Scholarship Opportunities
    • 27-Year-Old Dies Following NAD+ Infusion at New York Wellness Center
    • Cavin CPAs & Advisors Becomes Platinum Vendor Affiliate with the American Med Spa Association
Advertisement